Clyde W. Yancy et al. JACC 2017;70:

Slides:

Advertisements

Similar presentations

Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):

Advertisements

The percentage of values for cardiac troponin (cTn)T associated with elevated values for a point-of-care assay with less sensitivity and precision: the.

Mahmoud Farhoud, MD 1,2, Paul Ndunda, MD 2,K James Kallail, PhD 2, Hussam Farhoud, MD, FACC 3 1 University of Central Florida College of Medicine, 2 University.

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Utility of B-type natriuretic peptide in the diagnosis.

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure Developed in Collaboration With the American Academy.

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure Clyde W. Yancy, MD, MSc, MACC, FAHA, FHFSA, Mariell.

Volume 69, Issue 2, Pages (February 2017)

The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent.

Volume 14, Issue 8, Pages e218-e254 (August 2017)

Stephen W. Waldo et al. JACC 2008;51:

Glenn N. Levine et al. JACC 2016;68:

Cardiac Biomarkers.

Glenn N. Levine et al. JACC 2016;68:

Biomarkers in Heart Failure

Reproduced with permission from Yancy, C. W. et al. 2017

Median NT-proBNP levels (pg/mL) by GFR and 60-day survival

Diabetes Mellitus and Heart Failure

Clyde W. Yancy et al. JACC 2017;70:

Volume 14, Issue 8, Pages e155-e217 (August 2017)

The Utility of Biomarkers in Sorting Out the Complex Patient

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome.

Biomarker-Guided HF Therapy: Is It Cost-Effective?

Stavros V. Konstantinides et al. JACC 2016;67:

Dean J. Kereiakes et al. JACC 2017;70:

Orly Vardeny et al. JCHF 2014;2:

G. Michael Felker et al. JCHF 2014;2:

Editorial Heart Failure Clinics

Overcoming Clinical Inertia

Johannes Steiner et al. JACC 2017;70:

Incremental predictive value of CR after repetitive squatting exercise and FC from cardiopulmonary testing exercise results over clinical (red) and echocardiographic.

Nicholas Wettersten, MD, Alan S. Maisel, MD

Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea George A. Alba, MD, Quynh A. Truong,

John A. Bittl et al. JACC 2016;68:

Matthew Oster et al. JACC 2019;73:

An expert proposal for a treat-to-target checklist for pulmonary arterial hypertension (PAH). An expert proposal for a treat-to-target checklist for pulmonary.

Peter E. Carson et al. JCHF 2015;3:

Maria R. Costanzo et al. JCHF 2016;4:

Contemporary Considerations in Biomarker-Guided Therapy

Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies (2,9) Green diamonds indicate Class I guideline recommendations, while.

Risk assessment and treat-to-target approach for pulmonary arterial hypertension. Risk assessment and treat-to-target approach for pulmonary arterial hypertension.

Emilce Trucco et al. JACEP 2018;j.jacep

Combined Use of the Novel Biomarkers High-Sensitivity Troponin T and ST2 for Heart Failure Risk Stratification vs Conventional Assessment Josep Lupón,

Behnam N. Tehrani et al. JACC 2019;73:

Rami Doukky et al. JCHF 2016;4:24-35

Receiver operating characteristics curve of N-terminal pro-atrial natriuretic peptide plasma levels (dark line) and brain natriuretic peptide (dashed line)

Michael H. Chiu, MD, Msc, Nakul C. Sharma, MD, MPH CJC Open

Paul M. McKie, BS, John C. Burnett, MD Mayo Clinic Proceedings

When we compared cardiac volumes (ED and ES) between those with high BNP levels (BNP >400 pg/mL) and low BNP (

Jeffrey L. Anderson et al. JACC 2007;50:e1-e157

Glenn N. Levine et al. JACC 2011;58:e44-e122

Svend A. Mortensen et al. JCHF 2014;2:

Receiver-operating characteristics analyses for predicting AKI progression or AKI progression with death. Receiver-operating characteristics analyses for.

N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels for patients undergoing surgical aortic valve replacement (SAVR) (A), patients undergoing.

Lee A. Fleisher et al. JACC 2014;64:e77-e137

Rick A. Nishimura et al. JACC 2014;63:e57-e185

Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:

Results of classification and regression tree analysis in patients with pulmonary hypertension-sickle cell disease. Results of classification and regression.

The possible off-target effect of increased heart failure hospitalizations from saxagliptin in the SAVOR trial. The possible off-target effect of increased.

Figure 1 Novel markers of increased stroke risk in AF

Rick A. Nishimura et al. JACC 2017;70:

Zeenat Safdar et al. JCHF 2014;2:

Associations of peripartum biomarker levels with e' at 1 month postpartum (PP2). Associations of peripartum biomarker levels with e' at 1 month postpartum.

Analysis of receiver operating characteristic of three models (model 1: cardiac troponin T (cTnT), N-terminal pro brain natriuretic peptide (NT-proBNP),

Spearman’s rank correlation between preoperative serum levels of BNP/NT-proBNP and expression of HIF-2 alpha and preoperative serum level of VEGF. There.

Changes in the plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) level from baseline to treatment titration and 3 months of therapy: full analysis.

Flow diagram of the recommended pharmacological management of heart failure adapted from the European Society of Cardiology guidelines Flow diagram.

Receiver operating curves assessing the prognostic accuracy of a) N-terminal pro-brain natriuretic peptide, b) pro-atrial natriuretic peptide, c) high-sensitivity.

Overall survival in all cases.

Standardised regression coefficients between blood variable levels and echocardiographic measurements. Standardised regression coefficients between blood.

Mayo Clinic Proceedings

Presentation transcript:

Clyde W. Yancy et al. JACC 2017;70:776-803 Biomarkers Indications for Use Colors correspond to COR in Table 1. *Other biomarkers of injury or fibrosis include soluble ST2 receptor, galectin-3, and high-sensitivity troponin. ACC indicates American College of Cardiology; AHA, American Heart Association; ADHF, acute decompensated heart failure; BNP, B-type natriuretic peptide; COR, Class of Recommendation; ED, emergency department; HF, heart failure; NT-proBNP, N-terminal pro-B-type natriuretic peptide; NYHA, New York Heart Association; and pts, patients. Clyde W. Yancy et al. JACC 2017;70:776-803 2017 American College of Cardiology Foundation, the American Heart Association, Inc., and the Heart Failure Society of America